BK virus immune response study in lung transplant patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the immune system of lung transplant recipients responds to a common virus called BK virus, which can sometimes cause problems after a transplant. It aims to help doctors better understand and manage the virus in transplant patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have received a lung transplant at the Strasbourg University Hospital between June 30, 2018, and December 31, 2022.
- You must be at least 18 years old.
- You must be able to give written consent to participate.
- You must be affiliated with the French Social Security system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an experimental drug can prevent a common virus (EBV) from causing problems in people who receive a kidney from an EBV-positive donor but have never been exposed to EBV themselves. It aims to reduce the risk of transplant-related complications.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
This study is creating a registry to learn how the immune system responds to BK virus in people who have recently received a kidney transplant from a deceased donor. Researchers hope this information will help improve treatment for BK virus infections.
This study looks at how the immune system responds to BK virus in people who have had a kidney transplant. The virus can sometimes cause problems with the new kidney, so researchers want to compare the immune responses in patients who have the virus with those who don't, and with healthy people.
This study looks at how often BK virus shows up in people after a combined liver-kidney transplant. It may help the transplant team better predict and manage this virus after surgery.
This study looks at whether BK virus can be found in the saliva of people who have had a kidney transplant, which could help doctors understand and monitor the virus more easily. If you've had a kidney transplant, this study may help improve care for people like you.
Hear when a new Graft Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.